In this continuation of our myeloma series, we discuss the progression of MGUS & smoldering myeloma to multiple myeloma. We also outline how to risk stratify a patient with multiple myeloma and gauge their response to treatment.

Content:

-What is the natural progression from MGUS to smoldering myeloma to multiple myeloma?

- How do we risk stratify patients with a new myeloma diagnosis?

- What is the role of FISH/karyotype in risk stratification in myeloma?

-How do we gauge disease response in myeloma?

- How do we define disease progression?

- How do we define treatment response?

- What is the role of minimal residual disease (MRD) in myeloma?

Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

This episode has been sponsored by Primum. To sign up for a free account, check out: tfoc.primum.co

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

Episode 042: Myeloma Series, Pt.3 - Intro to Multiple Myeloma

The Fellow on Call: The Heme/Onc Podcast

Episode 042: Myeloma Series, Pt.3 - Intro to Multiple Myeloma